Uveitis, Evaluation and Treatment: Multimedia

References

1. Opremcek EM. Uveitis. In: A Clinical Manual for Ocular Inflammation. New York: Springer-Verlag; 1995.

2. Smith RE, Nozik RA. Uveitis. In: A Clinical Approach to Diagnosis and Management. 3^rd ed. Lippincott Williams & Wilkins; 2003.

3. Rosenbaum JT, Wernick R. The utility of routine screening of patients with uveitis for systemic lupus erythematosus or tuberculosis. A Bayesian analysis. Arch Ophthalmol. Sep 1990;108(9):1291-3. [Medline].

4. Sackett DL, Richardson WS, Rosenberg W, Haynes B. Evidence-based medicine. In: How to Practice and Teach EBM. ed. Harcourt Health Sciences; 1996.

5. Sandler G. The importance of the history in the medical clinic and the cost of unnecessary tests. Am Heart J. Dec 1980;100(6 Pt 1):928-31. [Medline].

6. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. Sep 2005;140(3):509-16. [Medline].

7. Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer EM, D'Amico DJ, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. May 1996;114(5):593-9. [Medline].

8. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. Mar 2004;111(3):491-500; discussion 500. [Medline].

9. Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. Feb 15 1987;103(2):131-6. [Medline].

10. George RK, Walton RC, Whitcup SM, Nussenblatt RB. Primary retinal vasculitis. Systemic associations and diagnostic evaluation. Ophthalmology. Mar 1996;103(3):384-9. [Medline].

11. Dev S, Mieler WF, Pulido JS, Mittra RA. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Ophthalmology. Jun 1999;106(6):1086-90. [Medline].

12. American Academy of Ophthalmology. Section 9. Intraocular inflammation and uveitis. In: Basic and Clinical Science Course. San Francisco, Calif: American Academy of Ophthalmology; 2007-2008.

13. Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. Dec 2005;140(6):1096-105. [Medline].

14. Canadian Medical Association Journal. How to read clinical journals: II. To learn about a diagnostic test. Can Med Assoc J. Mar 15 1981;124(6):703-10. [Medline].

15. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. Jul-Aug 2005;50(4):364-88. [Medline].

16. Chang TS, Aylward GW, Davis JL, Mieler WF, Oliver GL, Maberley AL, et al. Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis. Retinal Vasculitis Study. Ophthalmology. Jul 1995;102(7):1089-97. [Medline].

17. Fagan TJ. Letter: Nomogram for Bayes theorem. N Engl J Med. Jul 31 1975;293(5):257. [Medline].

18. Foster CS, Rashid S. Management of coincident cataract and uveitis. Curr Opin Ophthalmol. Feb 2003;14(1):1-6. [Medline].

19. Foster CS, Vitale AT. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders; 2002.

20. Gunduz K, Pulido JS, McCannel CA, O'Neill BP. Ocular manifestations and treatment of central nervous system lymphomas. Neurosurg Focus. 2006;21(5):E9. [Medline].

21. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. Oct 2000;130(4):492-513. [Medline].

22. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. Feb 2 1994;271(5):389-91. [Medline].

23. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. Mar 2 1994;271(9):703-7. [Medline].

24. Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. Oct 1984;91(10):1247-52. [Medline].

25. Kerkhoff FT, Lamberts QJ, van den Biesen PR. Rhegmatogenous retinal detachment and uveitis. Ophthalmology. Feb 2003;110(2):427-31. [Medline].

26. LeHoang P, Ozdemir N, Benhamou A, Tabary T, Edelson C, Betuel H, et al. HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol. Jan 15 1992;113(1):33-5. [Medline].

27. Lobo A, Lightman S. Vitreous aspiration needle tap in the diagnosis of intraocular inflammation. Ophthalmology. Mar 2003;110(3):595-9. [Medline].

28. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. Jan 1996;121(1):35-46. [Medline].

29. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis. In: Fundamentals and Clinical Practice. 3^rd ed. Mosby-Year Book; 2004.

30. Quillen DA, Davis JB, Gottlieb JL, Blodi BA, Callanan DG, Chang TS, et al. The white dot syndromes. Am J Ophthalmol. Mar 2004;137(3):538-50. [Medline].

31. Rosenbaum JT, Holland GN. Uveitis and the Tower of l. Arch Ophthalmol. May 1996;114(5):604-5. [Medline].

32. Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A, Alberts C, et al. Uveitis and systemic disease. Br J Ophthalmol. Mar 1992;76(3):137-41. [Medline].

33. Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology. In: A Basic Science for Clinical Medicine. 2^nd ed. Lippincott-Raven Publishers; 1991.

34. Theodossiadis PG, Markomichelakis NN, Sfikakis PP. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina. Apr-May 2007;27(4):399-413. [Medline].

Further Reading

Keywords

ocular inflammation, anterior uveitis, ocular inflammatory diseases, ocular infectious diseases, eye diseases, iritis, iridocyclitis, intermediate uveitis, pars planitis, panuveitis, diffuse uveitis, posterior uveitis, choroiditis, retinitis, vitritis, ocular immune phenomena, systemic diseases with ocular manifestations

Contributor Information and Disclosures

Author

Robert H Janigian Jr, MD, Clinical Assistant Professor, Department of Surgery (Ophthalmology), Brown University Medical School
Robert H Janigian Jr, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Retina Specialists, and Rhode Island Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

David Young, MD, Staff Physician, Department of Ophthalmology, Rhode Island Hospital, Brown University
David Young, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

John D Sheppard, Jr, MD, MMSc, Associate Professor of Ophthalmology, Microbiology and Immunology, Director for Thomas R Lee Center for Ocular Pharmacology, Director, Uveitis Service, Eastern Virginia School of Medicine; Consulting Staff, Virginia Eye Consultants
John D Sheppard, Jr, MD, MMSc is a member of the following medical societies: American Academy of Ophthalmology, American Society for Microbiology, American Uveitis Society, Association for Research in Vision and Ophthalmology, and Contact Lens Association of Ophthalmologists
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

R Christopher Walton, MD, Professor, Director of Uveitis and Ocular Inflammatory Diseases Service, Assistant Department of Ophthalmology, Assistant Dean for Graduate Medical Education and Continuing Education, University of Tennessee College of Medicine; Consulting Staff, Regional Medical Center, Memphis Veterans Affairs Medical Center, St Jude Children's Research Hospital
R Christopher Walton, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Healthcare Executives, American Uveitis Society, Association for Research in Vision and Ophthalmology, and Retina Society
Disclosure: Nothing to disclose.

CME Editor

Ralph Garzia, OD, Assistant Dean for Clinical Programs, Associate Professor, School of Optometry, University of Missouri at St Louis
Ralph Garzia, OD is a member of the following medical societies: American Academy of Optometry and American Optometric Association
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.